• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Alkermes(ALKS.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec16
BlackRock Completes Significant Voting Shares Acquisition in ALKEM
11:46
Dec12
BlackRock Acquires Shares in Alkermes
11:46
Dec1
Alkermes Executives Disposed of Company Stocks
22:42
Nov19
Alkermes Increases Bid for Avadel Pharmaceuticals to $2.37 Billion
11:07
Alkermes Increases Bid for Avadel
11:01
Nov17
Truist Financial Analyst Maintains Buy Rating on Alkermes with a Price Target of $55
12:52

Schedules & Filings

Schedules
Filings
Oct28
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 394.19 M, Net Income 82.76 M, EPS 0.49

Jul29
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 390.66 M, Net Income 87.1 M, EPS 0.52

May1
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 306.51 M, Net Income 22.46 M, EPS 0.13

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TMDE
1.091
+146.32%
+0.656
INBS
13.690
+73.51%
+5.690
VRME
1.060
+57.13%
+0.384
MNTS
9.000
+56.79%
+3.260
UFG
1.100
+51.71%
+0.370
LHSW
0.7999
+46.10%
+0.252
JCSE
1.530
+42.99%
+0.460
DVLT
1.435
+42.08%
+0.421
RDACR
0.2499
+37.23%
+0.068
PXIU
2.342
+36.94%
+0.632
View More